Skip to Content
Søg Menu

Superior safety profile for decitabine vs chemotherapy for older patient with AML

/ BestPractice Nordic
EHA22AML

Oncogeriatric screening using electronic PROMs

/ Gabor Liposits / Liv Marit Valen Schougaard / Halla Skuladottir
AlderdomCancerPatientinddragelse

A novel CAR-T cell therapy thas proven highly effective for patients with RRMM

/ BestPractice Nordic
CAR-TEHA22Myelomatose

A new phase 3 trial shows significantly prolonged overall survival for patients with AML

/ BestPractice Nordic
EHA22AML

Improved PFS is achievable using targeted therapy combinations with venetoclax in fit patients with treatment naïve CLL 

/ BestPractice Nordic
EHA22CLL

Treatment of Burkitt lymphoma with DA-EPOCH-R is associated with significant less infectious complications, transfusions, and hospitalization days 

/ BestPractice Nordic
EHA22LymfomKemoterapi

Phase 2 study update: Epcoritamab demonstrates clinically meaningful and compelling efficacy in the treatment of R/R large B-cell lymphoma 

/ BestPractice Nordic
EHA22Lymfom

Søvnapnø – den ukendte folkesygdom kræver handling

/ Thora Thomsen / Louise Rabøl / Mette Bierbum Bacher
Søvnproblemer

Novel Agent Increases PFS for Patients with endocrine-resistant HR+/HER2- metastatic breast cancer

/ BestPractice Nordic
HER2ASCO22Brystcancer

Ibrutinib added to Standard-of-Care Therapy improves PFS by 50% for Older Patients with Newly Diagnosed Mantle Cell Lymphoma

/ BestPractice Nordic
ASCO22Lymfom
Back to top